Uppsala Monitoring Centre

30/05/2026

New webinar: Reciprocal Effects of Drugs & the Microbiome

Research on the is reshaping our understanding of health, disease, and medicines. Join the Council for International Organizations of Medical Sciences (CIOMS) to learn more about current evidence, regulatory implications, and priorities for future guidance on drug–microbiome interactions:

📆 Wednesday, 10 June 2026
🕑 14:00 – 15:30 CEST
🖥️ Online

Register to attend here 👉 https://ow.ly/Viaa50Z5vl8

28/05/2026

Are you attending this year's ISoP Online Mid-Year Symposium?

Be sure to listen to UMC's Michele Fusaroli deliver an oral presentation exploring how the implementation of a data-driven filter for spurious drug-event combinations emerging from disproportionality analysis to support signal triage.

📆 Wedneday, 10 June 2026
🕙 10:15 BST
📍 Hatfield, UK 🇬🇧

Register to attend and explore the conference programme here 👉 https://ow.ly/M09L50YUsYV

27/05/2026

Following the ISoP Africa Chapter Meeting, UMC was pleased to participate in a workshop on detecting, classifying, and responding to Adverse Events of Special Interest (AESIs) for vaccine safety surveillance in Africa.

Held in Windhoek, Namibia🇳🇦, the event brought together participants from pharmacovigilance centres and immunisation programmes across 15 African countries for practical, hands‑on training using real‑world scenarios, demonstrating how UMC tools ( and ) and resources can be used to detect AESIs. The workshop also explored how resources offered by Safety Platform for Emergency Vaccines (SPEAC) and Brighton Collaboration can be utilised alongside UMC resources to improve AESI identification, triage discipline, signal detection, and proportionate regulatory decision‑making during emergency vaccine rollouts.

Thank you to workshop coordinators, Africa CDC, Coalition for Epidemic Preparedness Innovations - CEPI and SPEAC, and attendees for a fruitful training session!

26/05/2026

From bandages to pacemakers, medical devices play a vital role in modern healthcare and in the daily lives of patients. Monitoring the safety of these devices can be complex, as it must consider not only medical risks, but also technological and engineering risks, such as cybersecurity threats or outdated software.

In this two-part episode, Omar Aimer, President of ISoP Online, breaks down medical device vigilance and shares how global initiatives are working to strengthen safety monitoring standards.

🎧 Listen to for more 👉 https://ow.ly/M36I50Y8JKZ

25/05/2026

UMC welcomes the new resolution "Advancing smart, efficient pharmacovigilance as an essential tool for robust, sustainable, resilient and responsive health systems, for everyone, everywhere", adopted at the World Health Assembly , which concluded this weekend.

The resolution is a significant recognition by the World Health Organization (WHO) of the ongoing role that pharmacovigilance plays in protecting patients and strengthening health systems worldwide, particularly in an era of rapid medical innovation and increasing global use of health products.

We are honoured that the resolution recognises our support to member states over nearly five decades and the contributions that UMC continues to make to global health.

Read the full resolution here 👉 https://ow.ly/ornF50Z3KC7
Learn more about how UMC supports global pharmacovigilance on our website 🌐 https://ow.ly/3Qmo50Z3KC8

📷 WHO

22/05/2026

Would you like to be part of a team that builds software for the safer use of medicines and vaccines globally?

We're a Project Leader to join our Product Management section to plan, organise, and lead projects within our two product portfolios. Working with Product Managers, team members, and other stakeholders, you will ensure successful outcomes according to agreed scope, time, and objectives throughout the product lifecycle.

Learn more about this opportunity and apply by 27 May 2026 at this link 👉 https://ow.ly/y0B650Z2JaZ

21/05/2026

📰 Hot off the press – discover how human, animal, and environmental health are inextricably linked in the latest issue of .

Turn the pages to learn:
• What the four key principles of the Approach are
• How diclofenac unleashed a rabies crisis
• How pharmaceuticals in the environment contribute to
• How can help address AMR

Alongside our featured One Health series, this issue brings you global perspectives on digital innovation, substance misuse reporting, and updates to the VigiBase database.

Read the issue today 👉 https://ow.ly/3Ty050Z2JPr

20/05/2026

The future of in Africa took centre stage at this year's Chapter Meeting as regulators, healthcare professionals, industry, academia, and international organisations gathered in Namibia🇳🇦.

A strong sense of optimism surrounded the discussions as the African Medicines Agency moved from vision to reality. Collaboration across countries and organisations emerged as a key theme to realise a new era of PV that is stronger, more harmonised, digitally enabled, and supports resilient health systems across the continent.

UMC was pleased to contribute through an educational workshop on effective communications and a session exploring how adverse event data can help flag issues related to substandard and falsified medicinal products. Thank you to everyone who stopped by our booth to explore the and learn how VigiFlow and its connected applications are ready to support regional safety reporting and surveillance to AfriVigilance.

Thank you to the conference hosts, ISoP Africa Chapter and the Ministry of Health and Social Services of Namibia, as well as speakers, sponsors, and attendees, for making this a valuable and memorable event 👏

ISoP Online

19/05/2026

🎥 Collaboration is the foundation of medicines and vaccine safety. Brazil's system is no exception.

Since 2020, Anvisa has required marketing authorisation holders to submit safety data via Med Empresas ( eReporting for Industry), with UMC's Drug Dictionary, Global, now mandatory for coding safety data.

Local stakeholders, including Instituto Butantan and the pharmaceutical industry, are utilising these tools to code pre- and post-marketing data and manage adverse event reports in a standardised and harmonised way. This enables all parties to speak a common language when it comes to .

👀 Watch the film below to learn more, and explore the rest of the series on YouTube 👉 ow.ly/j81o50QPVtJ

18/05/2026

🫀Stents, injection needles, ECG monitors. These are just some of the that nearly every patient treated at Mexico's Instituto Nacional de Cardiología Ignacio Chávez (INC) will encounter.

To better detect, analyse, and monitor medical device-related incidents, the INC established a dedicated centre, the first of its kind in a clinical setting in Mexico🇲🇽.

Learn how the INC's efforts have gone beyond detecting safety problems to actively preventing medical device-related harm and keeping hearts beating in 👇

A Mexican cardiology hospital became the first to establish a dedicated technovigilance centre in a clinical setting, and its work is already contributing to patient safety.